Companies: 10,795·Total market cap: $144.5T
Drugs Made In America Acquisition II Corp. Unit

Drugs Made In America Acquisition II Corp. Unit

DMIIUNASDAQFinancial Services● Active
$10.23
+$0.07(+0.69%)
Market Cap$711087400
P/E Ratio—
52W High$10.8
52W Low$9.935
Overview

Drugs Made In America Acquisition II Corp. Unit (DMIIU) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

DMIIU · earnings · updated Jun 9, 2026

No earnings history available.

Next Earnings Date

Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
No earnings history available.
No analyst estimates available for DMIIU.

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: DMIIU ends December

Drugs Made In America Acquisition II Corp. Unit (DMIIU) reports earnings quarterly as a NASDAQ-listed Asset Management company. The next DMIIU earnings date is expected around September 1, 2026.

Each quarter, investors track DMIIU earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DMIIU revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DMIIU's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
RevenuePrice historyFinancial statementsForecastDividendsMarket cap

Frequently asked questions

DMIIU earnings · 3 questions

Drugs Made In America Acquisition II Corp. Unit's next earnings report is expected around September 1, 2026. DMIIU typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DMIIU historically reports after market close (AMC).

DMIIU earnings datewhen is DMIIU earningsDMIIU next earnings datewhen does DMIIU report earningsDMIIU earnings calendar

▸ Source: FMP · Drugs Made In America Acquisition II Corp. Unit SEC filings · US GAAP · Drugs Made In America Acquisition II Corp. Unit SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026